Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119522) titled 'The clinical value of magnetic resonance and ultrasound in the diagnosis of different molecular subtypes of breast cancer' on Feb. 28.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Ningbo Medical Centre Lihuili Hospital
Condition:
breast cancer
Intervention:
Triple-negative group :None
HER2 overexpression group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-28
Target Sample Size: Triple-negative group :10;HER2 overexpression group:26;Luminal group:70;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...